Status:
UNKNOWN
Efficacy and Safety of Intravitreal Triamcinolone Acetonide in Eyes With Post Vitrectomy Diabetic Vitreous Hemorrhage
Lead Sponsor:
Asan Medical Center
Conditions:
Post Vitrectomy State
Recurrent Diabetic Vitreous Hemorrhage
Eligibility:
All Genders
20+ years
Phase:
NA
Brief Summary
The Purpose of this study is compare the efficacy of intravitreal triamcinolone in clearing recurrent post-vitrectomy diabetic hemorrhage with conventional treatment, air-fluid exchange.
Detailed Description
Vitreous hemorrhage is the most common complication of vitrectomy for diabetic retinopathy. Despite measures to prevent and control this bleeding, it can lead to air-fluid exchange in the office or to...
Eligibility Criteria
Inclusion
- Previous vitrectomy due to proliferative diabetic retinopathy
- Recurrent diabetic vitreous hemorrhage
Exclusion
- Monocular vision
- Uncontrollable intraocular pressure
Key Trial Info
Start Date :
January 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2007
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00300014
Start Date
January 1 2006
End Date
May 1 2007
Last Update
June 13 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Asan Medical Center
Seoul, South Korea, 138-736